Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

The utility of fecal calprotectin (fCal) in small bowel Crohn's disease (CD) remains to be clarified. The primary aim of this study was to determine levels of fCal in CD restricted to the small bowel compared with CD affecting the colon, in patients undergoing their first diagnostic work-up. In addition, the study assessed the sensitivity and specificity of fCal in suspected CD.
Original languageEnglish
JournalScandinavian Journal of Gastroenterology
Volume46
Issue number6
Pages (from-to)694-700
ISSN0036-5521
DOIs
Publication statusPublished - 2011

Keywords

  • Adolescent
  • Adult
  • Aged
  • Biological Markers
  • Capsule Endoscopy
  • Cohort Studies
  • Colon
  • Crohn Disease
  • Feces
  • Female
  • Humans
  • Intestine, Small
  • Leukocyte L1 Antigen Complex
  • Male
  • Middle Aged
  • Prospective Studies
  • Sensitivity and Specificity
  • Single-Blind Method
  • Young Adult

Fingerprint

Dive into the research topics of 'Fecal calprotectin is equally sensitive in Crohn's disease affecting the small bowel and colon'. Together they form a unique fingerprint.

Cite this